We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Risky Business
Q&A with CSL’s Chief Risk Officer Karen Neave.
3 Tips for Advancing Your Biotech Career
CSL’s Executive Vice President and Head of R&D offers advice for professional development.
Behind the Scenes With Our CEO
It’s lights, camera, action as CSL chief Paul Perreault films employee messages in our U.S. studio.
Explainer: What’s Real World Evidence?
Tapping all sources of data gives a fuller picture of patient experience.
How to Build a Global Brand
A Q & A with Chief Communications Officer Anthony Farina.
Paul Perreault on Innovation and Biotech
CEO and Managing Director sits down with NPR affiliate to discuss evolving industry.
Biotechnology in Dubai
CSL Behring opens regional HQ in iconic desert city.
Sharing Biotech Innovation at Penn State
CSL CEO Paul Perreault highlights ongoing partnership during PSU appearance.
Feeling Alone, Facing a Rare Disease
How can we improve access to treatment for patients?
Breaking Down Barriers for Patients
Why improving access to care is on my mind this February – and every day.
Medicaid a Winner in U.S. Midterm Election
Expanded coverage in 3 states expected to help those with rare and serious diseases.
The Impact of Sickle Cell Disease
Why CSL Behring is exploring new treatment options for this rare disease.
Popular search terms:
Americas
Asia Pacific
Europe
